Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new software revision, v3.5.4, was added and the previous revision, v3.5.3, was removed. This indicates an update to the site's underlying platform, likely including fixes or minor enhancements.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s displayed ClinicalTrials.gov release/version indicator was updated from “v3.5.2” to “v3.5.3.” This reflects a site revision rather than a change to the study details.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.5.2 was applied, replacing v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision number updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check108 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating an administrative update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.